Vol 11, No 10 (October 31, 2022): Translational Lung Cancer Research

Original Article

Plasma cell-free DNA and circulating tumor cells as prognostic biomarkers in small cell lung cancer patients
Patricia Mondelo-Macía, Jorge García-González, Alicia Abalo, Manuel Mosquera-Presedo, Santiago Aguín, María Mateos, Rafael López-López, Luis León-Mateos, Laura Muinelo-Romay, Roberto Díaz-Peña
Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO
Christian Grohé, Thomas Wehler, Tobias Dechow, Sven Henschke, Wolfgang Schuette, Ina Dittrich, Stefan Hammerschmidt, Harald Müller-Huesmann, Christian Schumann, Stefan Krüger, Judith Atz, Rolf Kaiser
Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure
Neetha Nanoth Vellichirammal, Abrar Albahrani, Chittibabu Guda
Cannabinoid receptor 2 expression in early-stage non-small cell lung cancers identifies patients with good prognosis and longer survival
Monika Vidlarova, Emil Berta, Petr Prasil, Andrea Prokopova, Sona Gurska, Marta Khoylou, Alona Rehulkova, Pavla Kourilova, Josef Chudacek, Marek Szkorupa, Jiri Klein, Jozef Skarda, Josef Srovnal, Marian Hajduch
FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
Pascal Hannequin, Chantal Decroisette, Pascale Kermanach, Giulia Berardi, Vincent Bourbonne
Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients
Andrey Alexeyenko, Odd Terje Brustugun, Inger Johanne Zwicky Eide, Radosveta Gencheva, Zeinab Kosibaty, Yi Lai, Luigi de Petris, Georgios Tsakonas, Oscar Grundberg, Bo Franzen, Kristina Viktorsson, Rolf Lewensohn, Per Hydbring, Simon Ekman
A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma
Shouzheng Ma, Jun Zhu, Mengmeng Wang, Jianfei Zhu, Wenchen Wang, Yanlu Xiong, Runmin Jiang, Nagarashee Seetharamu, Fernando Conrado Abrão, Vinayaga Moorthi Puthamohan, Lei Liu, Tao Jiang
A novel approach for the non-invasive diagnosis of pulmonary nodules using low-depth whole-genome sequencing of cell-free DNA
Bin Zhang, Han Liang, Weiran Liu, Xinlan Zhou, Sitan Qiao, Fuqiang Li, Pengfei Tian, Chenguang Li, Yuchen Ma, Hua Zhang, Zhenfa Zhang, Shigeki Nanjo, Alessandro Russo, Joan Anton Puig-Butillé, Kui Wu, Changli Wang, Xin Zhao, Dongsheng Yue
The efficacy and safety of immune checkpoint inhibitors combined with chemotherapy or anti-angiogenic therapy as a second-line or later treatment option for advanced non-small cell lung cancer: a retrospective comparative cohort study
Bolin Chen, Jingyi Wang, Xingxiang Pu, Jia Li, Qianzhi Wang, Liyu Liu, Yan Xu, Li Xu, Yi Kong, Kang Li, Fang Xu, Shuzhi Liang, Andrés F. Cardona, Lin Wu
Uniportal video-assisted thoracic surgery basal segmentectomy: a single-center retrospective cohort study
Yudong Tang, Chengwu Liu, Chenglin Guo, Qiang Pu, Jiandong Mei, Yunke Zhu, Lin Ma, Patrick Zardo, Paolo A. Ferrari, Kyoji Hirai, Hitoshi Igai, Zeead M. AlGhamdi, Lunxu Liu
KRAS mutation predict response and outcome in advanced non-small cell lung carcinoma without driver alterations receiving PD-1 blockade immunotherapy combined with platinum-based chemotherapy: a retrospective cohort study from China
Qianni Li, Qi Zhou, Shicai Zhao, Peng Wu, Ping Shi, Jia Zeng, Xiaomin Xiong, Haiwen Chen, Muaiad Kittaneh, Sara Bravaccini, Michele Zanoni, Chengzhi Zhou, Jiexia Zhang